-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-1-inhibitor-46
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/332947-35-0.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 332947-35-0 |
| Description | HIV-1 inhibitor-46 (compound 13d) is a potent HIV-1 non-nucleoside reverse transcriptase inhibitor with an EC50 value of 1.425 μM. HIV-1 inhibitor-46 can be used for the research of AIDS. |
Product Information
| Synonyms | HIV-1 inhibitor-46|CHEMBL377896|ZINC888245|AKOS000409960|HY-147370|CS-0567628|2-[[5-benzyl-4-(p-tolyl)-1,2,4-triazol-3-yl]sulfanyl]-N-(2-chlorophenyl)acetamide|Acetamide, 2-[[5-benzyl-4-(4-methylphenyl)-4H-1,2,4-triazol-3-yl]thio]-N-(2-chloro)phenyl- |
| Molecular Weight | 448.97 |
| Molecular Formula | C24H21ClN4OS |
| Canonical SMILES | CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NC3=CC=CC=C3Cl)CC4=CC=CC=C4 |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 568 |
| Exact Mass | 448.1124602 |
| Target | HIV-1:1.425 μM (EC50) |
| XLogP3-AA | 5.8 |
